| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/09/2006 | US20060029616 live vector vaccine; removal of sole dependence on catalytic balanced lethal maintenance systems; plasmid partition system prevents random segregation; enhanced inheritance and stability; genetic engineering; antibiotic resistance |
| 02/09/2006 | US20060029615 Novel recombinant T4 phage particle and uses thereof |
| 02/09/2006 | US20060029611 Prevention and treatment of amyloidogenic disease |
| 02/09/2006 | US20060029609 administering drug biological conjugates used for the diagnosis, prophylaxis, or treatment of nervous system disorders or lysosomal storage diseases; drug delivery; blood brain barriers |
| 02/09/2006 | US20060029608 Immunization against clostridium difficile disease |
| 02/09/2006 | US20060029607 Methods and compositions for modulating tumor growth |
| 02/09/2006 | US20060029603 Immunoglobulins |
| 02/09/2006 | US20060029602 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 02/09/2006 | US20060029596 Administering to the tumor an adenovirus vector, overexpresses an adenovirus death protein; promoting the death of neoplastic cells; telomerase resistance; anticancer biodrugs |
| 02/09/2006 | US20060029595 Methods of using human receptor protein 4-1BB |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/09/2006 | US20060029586 Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 02/09/2006 | US20060029573 Pegylated interferon alpha-1b |
| 02/09/2006 | US20060029547 Generating prion specific immunoglobulin for use in diagnosis, prevention and treatment of neurodegenerative disorders |
| 02/09/2006 | US20060029545 Metal radionuclide complexed directly to a an annexin that has been modified to add a sulfhydryl group which participates in the complexation of the metal radionuclide; useful for imaging vascular thrombi |
| 02/09/2006 | DE102004034461A1 Gentherapie solider Tumore durch retrovirale, mit Arenavirus-Glykoprotein pseudotypisierte Vektoren Gene therapy of solid tumors by retroviral, with arena virus glycoprotein pseudotyped vectors |
| 02/09/2006 | DE102004031579A1 Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen Peptides to inhibit the interaction of protein kinase A and protein kinase A anchoring proteins |
| 02/09/2006 | CA2580313A1 Insulin-oligomer conjugates, formulations and uses thereof |
| 02/09/2006 | CA2579790A1 Npc1l1 and npc1l1 inhibitors and methods of use thereof |
| 02/09/2006 | CA2576124A1 Shigella mutants in the functions pertaining to the processes of maturing and recycling peptidoglycans and their uses as immunogens |
| 02/09/2006 | CA2575898A1 Vaccine for prevention and treatment of hiv-infection |
| 02/09/2006 | CA2575610A1 Hpv vaccine comprising peptides from host cell proteins |
| 02/09/2006 | CA2575606A1 Hai-1 and hai-2 in cancer therapy |
| 02/09/2006 | CA2575552A1 Notch mutations leading to increased receptor signaling |
| 02/09/2006 | CA2575533A1 Site specific system for generating diversity protein sequences |
| 02/09/2006 | CA2575127A1 Preparation of organisms with faster growth and/or higher yield |
| 02/09/2006 | CA2574791A1 Compositions and methods of using angiopoietin-like 4 protein |
| 02/09/2006 | CA2573113A1 Optimized interferon-beta gene |
| 02/09/2006 | CA2572294A1 Plant n-acylethanolamine binding proteins |
| 02/09/2006 | CA2571794A1 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions |
| 02/09/2006 | CA2571369A1 Antifungal polypeptides |
| 02/08/2006 | EP1624064A2 Nucleic acids and proteins from streptococcus pneumoniae |
| 02/08/2006 | EP1624063A2 Chimeric gene encoding the antigenic determinants of four proteins of L. infantum |
| 02/08/2006 | EP1624062A2 Human 7tm proteins and polynucleotides encoding them |
| 02/08/2006 | EP1624061A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1624057A2 Process for the obtention of a composition containing hyaluronidase |
| 02/08/2006 | EP1624055A1 Spheroid preparation |
| 02/08/2006 | EP1623995A1 Inhibitors of L1 and ADAM10 for the treatment of carcinomas |
| 02/08/2006 | EP1623994A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 02/08/2006 | EP1623993A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1623992A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1623991A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1623990A2 Compositions and methods for the treatment of tumours |
| 02/08/2006 | EP1623989A1 Compositions and methods for the diagnosis of tumours |
| 02/08/2006 | EP1623230A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 02/08/2006 | EP1623222A2 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 02/08/2006 | EP1623038A2 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 02/08/2006 | EP1623036A2 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2006 | EP1623033A1 Process of producing a plastid-targeted protein in plant cells |
| 02/08/2006 | EP1623028A1 Crystal structure of human coronavirus 229e main proteinase, and uses thereof for developing sars inhibitors |
| 02/08/2006 | EP1623024A2 Crystals of cytochrome p450 2c9, structures thereof and their use |
| 02/08/2006 | EP1623018A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 02/08/2006 | EP1623016A2 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3 |
| 02/08/2006 | EP1623015A2 Dna vaccine expressing ha1 of equine-2 influenza virus |
| 02/08/2006 | EP1623006A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 02/08/2006 | EP1622940A1 Analysis and use of par 1 polymorphisms for the risk estimation of cardiovascular diseases |
| 02/08/2006 | EP1622939A1 Active variants of the il-18 binding protein and medical uses thereof |
| 02/08/2006 | EP1622938A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 02/08/2006 | EP1622937A2 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 02/08/2006 | EP1622936A1 Method for the production of an n-terminally modified chemotactic factor |
| 02/08/2006 | EP1622935A2 Spex compositions and methods of use |
| 02/08/2006 | EP1622934A2 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof |
| 02/08/2006 | EP1622933A2 H. pylori antigens |
| 02/08/2006 | EP1622932A2 Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars) |
| 02/08/2006 | EP1622930A1 Template-fixed peptidomimetics as medicaments against hiv and cancer |
| 02/08/2006 | EP1622929A2 Apo2l (trail) receptor binding peptides and uses thereof |
| 02/08/2006 | EP1622927A2 Love variant regulator molecules |
| 02/08/2006 | EP1622921A2 Variants of beta-glucosidases |
| 02/08/2006 | EP1622644A2 Materials and methods for immunizing against fiv infection |
| 02/08/2006 | EP1622635A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 02/08/2006 | EP1622634A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/08/2006 | EP1622626A1 Regulation of cell surface proteins |
| 02/08/2006 | EP1622574A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/08/2006 | EP1622571A2 Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer |
| 02/08/2006 | EP1622570A2 Tissue protective cytokine receptor complex, assays for identifying tissue protective compounds and uses thereof |
| 02/08/2006 | EP1622568A2 Interleukin-9 antagonist muteins and their pharmacological methods of use |
| 02/08/2006 | EP1622566A2 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 02/08/2006 | EP1622563A2 Improved heat shock protein-based vaccines and immunotherapies |
| 02/08/2006 | EP1539798A4 Process for protein extraction |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1267904A4 Polypeptoid pulmonary surfactants |
| 02/08/2006 | EP1133556B1 Root-preferred promoters and their use |
| 02/08/2006 | EP1114062B1 Modified e.coli enterotoxin ii signal peptide and a microorganism expressing a fusion protein of said peptide and a heterologous protein |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1108058B1 Evolution of whole cells and organisms by recursive sequence recombination |
| 02/08/2006 | EP1032669B1 Recombinant allergen with reduced enzymatic activity |
| 02/08/2006 | EP0988045B1 Peptide nucleic acid monomers and oligomers |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | EP0951548B1 Mammalian icyp (iodocyanopindolol)receptor and its applications |
| 02/08/2006 | EP0948343B1 Alkyl peptide amides adapted for topical administration |
| 02/08/2006 | EP0946735B1 N-terminally extended proteins expressed in yeast |
| 02/08/2006 | EP0812356B1 Prostate-specific membrane antigen and uses thereof |
| 02/08/2006 | EP0765391B1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/2006 | EP0736041B1 Transparent liquid for encapsulated drug delivery |
| 02/08/2006 | EP0694067B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 02/08/2006 | EP0648266B1 Elicitor of the hypersensitive response in plants |
| 02/08/2006 | CN1732266A Plants having modified growth characteristics and a method for making the same |
| 02/08/2006 | CN1732265A Method for altering the content of reserve substances in plants |
| 02/08/2006 | CN1732263A Genes and proteins for the biosynthesis of the glycopeptide antibiotic A40926 |